Jay Amba Advanced Diagnostic Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 2.59 M
as on 16-11-2024
- Company Age 25 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.00 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit 81.13%
(FY 2023)
- Ebitda 75.92%
(FY 2023)
- Net Worth 263.13%
(FY 2023)
- Total Assets 399.85%
(FY 2023)
About Jay Amba Advanced Diagnostic Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.59 M.
The company currently has active open charges totaling ₹9.00 Cr.
Kiran Hatgaonkar, Renuka Potdar, and Shivanand Mishra serve as directors at the Company.
- CIN/LLPIN
U85195MH1999PTC119519
- Company No.
119519
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 1999
- Date of AGM
22 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Amravati, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jay Amba Advanced Diagnostic Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiran Hatgaonkar  | Managing Director | 25-Mar-2022 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Renuka Potdar | Director | 25-Mar-2022 | Current |
| Shivanand Mishra | Director | 25-Mar-2022 | Current |
Financial Performance of Jay Amba Advanced Diagnostic Laboratories.
Jay Amba Advanced Diagnostic Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 81.13% increase in profit. The company's net worth Soared by an impressive increase of 263.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jay Amba Advanced Diagnostic Laboratories?
In 2023, Jay Amba Advanced Diagnostic Laboratories had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Jul 2024 | ₹8.50 Cr | Open |
Others Creation Date: 02 Jul 2024 | ₹5.00 M | Open |
How Many Employees Work at Jay Amba Advanced Diagnostic Laboratories?
Unlock and access historical data on people associated with Jay Amba Advanced Diagnostic Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jay Amba Advanced Diagnostic Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jay Amba Advanced Diagnostic Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
